Alcon Canada Introduces the Clareon IOL with the AutonoMe Preloaded Intraocular Lens Delivery System

Alcon has announced a nationwide launch of the Clareon IOL with the AutonoMe delivery system in Canada. 

AutonoMe is an automated, disposable, preloaded IOL delivery system that enables precise delivery of the IOL into the capsular bag in patients undergoing cataract surgery, according to Alcon.^1-2 The device is being introduced with the Clareon IOL, a new BioMaterial with an advanced design that enables exceptional vision,¹ low edge glare and exceptional optic clarity.²

“The introduction of Clareon IOL with AutonoMe is an exciting addition to our surgical portfolio that will benefit surgeons and their patients undergoing cataract surgery,” Brian O’Neal, General Manager of Alcon Canada, said in a company news release. “Clareon IOL with AutonoMe delivery system builds upon the legacy of the AcrySof platform, enhanced with the newest optic material and a cutting-edge, intuitive and easy-to-use device that allows precise and controlled IOL delivery.”

The Clareon hydrophobic acrylic IOL is made of a patented optic polymer material. Clareon builds on and maintains the benefits of the AcrySof platform with a new optic BioMaterial that offers cataract patients exceptional optical clarity.^1,2,6,7

“Comfort and efficiency during the cataract surgery are key to achieving better outcomes,” said Dr. Pierre Faber, clinical professor in the Department of Ophthalmology and Visual Sciences at the University of British Columbia. “This new, easy-to-use device is great news for surgeons as it can improve the procedure with precise and controlled IOL delivery and may help reduce surgical time.”

The AutonoMe delivery system preloaded with the Clareon IOL is designed with advancements intended to benefit both surgeons and cataract patients. Its automated CO₂-powered delivery mechanism and intuitive, ergonomic design allow precise and simplified single-handed control of IOL placement during cataract surgery.^1,8

Following Health Canada approval in 2020, Alcon debuted the Clareon IOL with AutonoMe delivery system with a select group of Canadian ophthalmologists across the country and is now expanding availability nationwide.

References

1. Clareon^® AutonoMe™ IOL Directions for Use. 
2. Werner L, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019;45(10):1490-1497. doi:10.1016/j.jcrs.2019.05.017
3. National Institutes of Health (NIH), National Eye Institute (NEI), Eye Health Needs of Older Adults Literature Review, 2007. Available at: http://www.nei.nih.gov/nehep/research/The_Eye_Health_needs_of_Older_Adults_Literature_Review.pdf (link is external)
4. Flaxman AS, et al. Global causes of blindness and distance vision impairment 1990-2020: asystematic review and meta-analysis. Lancet Glob Health. 2017 Dec;5(12):e1221-e1234. doi: 10.1016/S2214-109X(17)30393-5.
5. National Institute for Health and Care Excellence, Cataracts in Adults: Management. Accessed September 2020.
6. Stanojcic N, et al. Effects of intraocular lens glistenings on visual function: a prospective study and presentation of a new glistenings grading methodology. BMJ Open Ophthalmology. 2019 Apr; 4(1):e000266. doi: 10.1136/bmjophth-2018-000266
7. Oshika T, Shiokawa Y, Amano S, et al. Influence of glistenings on the optical quality of acrylic foldable intraocular lens. British Journal of Ophthalmology 2001;85:1034-1037
8. Alcon data on file. 2019